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Abstract 
Lipid tubules are of particular interest for many potential applications in nanotechnology. 
Among various lipid tubule fabrication techniques, the morphological regulation of 
membrane structure by proteins mimicking biological processes may provide the chances 
to form lipid tubes with highly-tuned structures. Magnetotactic bacteria synthesize 
magnetosomes (a unique prokaryotic organelle comprising a magnetite crystal within a 
lipid envelope). MamY protein has previously been identified as the magnetosome protein 
responsible for magnetosome vesicle formation and stabilization. Furthermore, MamY has 
been shown in vitro liposome tubulation activity. In this study, the interaction of MamY 
and phospholipids was investigated by using a lipids-immobilized membrane strip and a 
peptide array. Here, the binding of MamY to the anionic phospholipid, cardiolipin, was 
found and enhanced liposome tubulation efficiency. We propose the interaction is 
responsible for recruiting and locating cardiolipin to elongate liposome in vitro. We also 
suggest a similar mechanism for the invagination site in magnetosomes vesicle formation, 
where the lipid itself contributes further to increasing the curvature. These findings are 
highly important to develop an effective biomimetic synthesis technique of lipid tubules 
and to elucidate the unique prokaryotic organelle formation in magnetotactic bacteria. 
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1 Introduction 
The fabrication of self-assembled lipid nanotubules in vitro is an exciting research 
topic because its applications are diverse. Using unique properties including structural 
flexibilities (e.g. diameter, length and wall thickness), ease of surface functionalization and 
biocompatibility, the materials can be used as nanoreactors for functional material 
synthesis[1–4], templating the fabrication of biocompatible functional one-dimensional 
materials[5–7] and drug carriers[8–10]. Because of these wide areas of interest, extensive 
research efforts have been devoted towards finding a means of creating such unique 
membrane structures in vitro and for elucidating the mechanisms of lipid tubule 
formation. 
Various fabrication techniques of lipid tubules have been developed since the first 
report in 1984[11] by self-assemble of diacetylene phospholipids. The techniques are 
generally categorized in two groups: the design of lipid molecules with appropriate 
structure and compositions for their self-assembling[12,13], and the morphological 
regulation by external stimuli such as pulling lipid vesicles with a pipette[14], electric 
fields[15], light irradiation[16], interaction with cationic particles[17] and proteins[18–20]. 
Among these approaches, the use of proteins mimicking biological systems is potential 
candidate for a range of lipid tubule formation with both highly-tuned and of more-
complicated structures because of the variety of precise protein-regulated membranous 
structures observed in biology (e.g. endoplasmic reticulum, Golgi network, inner 
mitochondrial membrane, etc.)[21–23].  
The protein-lipid interaction is an important part of regulating the membranous 
structure for cellular activity expressions. In eukaryotic cells, the Pleckstrin homology 
domain in phospholipase C-δ1 produces a pulling force of membranous structure to form 
a membrane compartment through the interaction with phosphorylated 
phosphatidylinositols[24]. The proteins possessing Bin/amphiphysin/Rvs (BAR) domain 
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also bound to phosphatidylinositols and the diverse BAR protein family including I-BAR 
and F-BAR have an important role for membrane invagination processes[23,25–28]. In 
prokaryotic cell, while the dynamic organization behaviors of lipid- protein localization for 
cell division have been investigated[29–33], research of protein-lipid interaction for 
prokaryotic organelle formation is lacking thus far. 
Magnetotactic bacteria are fascinating to many scientists due to the presence of 
prokaryotic membranous organelles, called magnetosomes, that comprise a crystalline 
magnetite core within a lipid envelope, or magnetosome membrane[34,35]. Previous 
molecular studies have reported that the complicated biomineralisation process is 
regulated by a unique set of proteins within the cells[36–40]. Briefly, magnetosome 
membranes are formed from cytoplasmic membrane through an invagination process[36,41] 
and the vesicles are then aligned along the actin-like filamentous protein[41–43]. Magnetite 
crystals are formed within magnetosome vesicles in a highly controlled manner regulated 
by a suite of magnetosome biomineralisation proteins [44–46]. During the organelle 
formation process, the interaction between specific membrane protein and lipids in the 
membrane might prove to be pivotal. Our research group has identified a magnetosome 
membrane protein, MamY, which has been isolated from magnetosome containing small 
magnetite crystal (presumably in immature stage)[47]. The mamY gene deletion mutant 
showed the expansion of magnetosome vesicle sizes and the increase of small magnetite 
crystals, showing MamY’s role in the vesicle invagination step. Furthermore, MamY can 
directly bind to biological membrane vesicles (liposome) and cause the deformation from 
sphere to tubule in vitro[47]. Therefore, while MamY is hypothesized to be related to the 
invagination of the magnetosome vesicle, the molecular mechanisms including protein-
membrane binding interactions are still unclear. 
Here, we investigated the interaction of the MamY protein and a range of lipids by 
(1) binding assay of MamY protein to various phospholipids, (2) evaluation of liposome 
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deformation efficiency by MamY protein in the presence of the best binding candidate 
lipid (cardiolipin (CL)), and (3) binding assay of a series of peptides derived from amino 
acid sequence of MamY protein to CL. This is the first report showing the direct interaction 
between a magnetosome membrane protein and specific lipids. The results in this study 
not only provide the preliminary understanding the presence of a unique protein-lipid 
interaction is responsible for magnetosome formation in magnetotactic bacteria, but also 
suggests of how prokaryotic protein could be used to biomimetically synthesize lipid 
tubule in vitro. 
 
2 Materials and methods 
2.1 Materials 
DOPC (1,2-dioleoyl-sn-glycero-3-phosphocholine, 18:1) and CL (Cardiolipin, 18:1) were 
purchased from Avanti Polar Lipids, Inc. (Alabaster, AL, USA). Membrane Lipid Strips were 
obtained from Echelon Bioscience, Inc. (Salt Lake, UT, USA). All other reagents were of the 
highest commercial grade available. M. magneticum AMB-1 (ATCC700264) was cultured 
anaerobically in magnetic spirillum growth medium (MSGM) in a 8-L fermentor as 
described previously[45,48].  
 
2.2 Lipid-strip binding assay 
The mamY gene was amplified from M. magneticum AMB-1 as previously described[47]. The 
gene of AmphiphysinBAR protein (human Amphiphysin aa1-239) was cloned into 
pGEX6p3. Recombinant proteins (MamY and AmphiphysinBAR) were expressed as fusion 
proteins with glutathione S-transferase (GST) using plasmid vector of pGEX6p-1 and 
pGEX6p-3, respectively (GE Healthcare Life Sciences, Chicago, Illinois, USA) in E. coli BL21. 
These recombinant proteins were purified with glutathione-sepharose, size-exclusion, and 
ion-exchange chromatography. Purity (>95%) of these proteins was verified by SDS-PAGE. 
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For the protein-lipid binding assay, various lipids dotted on strips (Echelon Bioscience 
Inc., Salt Lake, UT, USA) were blocked with PBS-T buffer (pH 7.4) (137 mM NaCl, 2.7 mM 
KCl, 4.3 mM Na2HPO4, 1.47 mM KH2PO4, 0.1% (v/v) Tween-20) supplemented with 3% 
BSA for 1h with gentle agitation 25oC. After discarding the blocking solution, protein 
solutions (0.5 μg ml-1 proteins in PBS) were incubated with gentle agitation for 1h at room 
temperature. The strips were then washed with PBS-T buffer three times with gentle 
agitation for 5 min each. The washed strips were incubated with mouse anti-GST antibody 
(GE Healthcare Life Sciences, Chicago, Illinois, USA) for 1 h and washed three times. Anti-
mouse IgG-HRP (Horseradish peroxidase) (Thermo Fisher Scientific, Waltham, 
Massachusetts, USA) was used as a secondary antibody and washed three times. The 
immunoreactivity was visualized with the ECL detection system (GE Healthcare Life 
Sciences, Chicago, Illinois, USA).  
 
2.3 Synthesis of peptide arrays 
Peptide library of 15-amino-acid peptides was constructed by overlapping 2 amino acids 
along the sequence of MamY protein and synthesized on cellulose membranes (grade 542; 
Whatman, Maidstone, UK) activated with β-alanine as N-terminus by peptide auto-spotter 
(MultiPep Rsi, Intavis AG, Köln, Germany) as shown in previous works [49,50]. It should be 
noted that the peptide array comprising the 15-mer peptides could reveal the importance 
of native secondary protein structure[63]. For the addition of each amino acid, the synthesis 
cycle began with deprotecting Fmoc-protecting group with 20% piperidine in N,N-
dimethylformamide (DMF) before washing the membrane with DMF and ethanol. Prior to 
amino acid coupling, Fmoc amino acids at 0.5 M were activated by 1.1 M 
Hydroxybenzotriazole and 1.1 M N,N-diisopropylcarbodiimide. After coupling, the 
remaining unreacted amino groups were blocked by 4% acetic anhydride in DMF and 
subsequently washed with DMF and ethanol. The synthesis was conducted according to 
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manufacturer’s instructions with some modifications. After the final cycle, Fmoc and side-
chain protecting groups were manually removed with 20% piperidine in DMF and mixture 
of Milli-Q water, triisopropyl silane and trifluoroacetic acid (2:3:95), respectively. Finally, 
the membrane was thoroughly washed with dichloromethane, DMF, ethanol and PBS.  
 
2.4 Liposome tubulation assay  
Cultured M. magneticum AMB-1 cells were resuspended in 10 mM HEPES buffer (pH 7.4) 
and disrupted twice by French press (2,000 kgf cm-3) on ice. After centrifugation, 
magnetosomes were collected magnetically by a cylindrical Nd-B magnet (15 mm in 
diameter, 10 mm in height). Total lipids from magnetosome membrane vesicle were 
extracted according to Bligh and Dyer extraction method[51]. A liposome tubulation assay 
was conducted as described previously[47,52] with minor modifications. Prior to making the 
liposome solution, glass vials were thoroughly washed with chloroform, methanol, MilliQ 
and chloroform. After mixing lipid components for liposome formation in chloroform, the 
solution was dried under argon gas purging and incubated in desiccator for more than 2h. 
As no tubulation was found for small unilamellar vesicle by MamY protein in our 
preliminary investigation, giant unilamellar vesicle (GUV) was applied for the tubulation 
assay. To form GUV, 0.3 M sucrose solution was added in the glass vial containing 
thoroughly dried lipid cake and were incubated overnight at 37°C. Liposomes (1 mg ml-1 
lipid) were then mixed with MamY-GST (final conc.: 30 μM). After incubation for 30 min at 
37°C, the samples were spotted onto 150-mesh carbon-coated copper grids (Nisshin EM 
Co., Tokyo, Japan), stained with 1% (w/v) phosphotungstic acid, and analyzed using JEOL 
JEM1200EX (JEOL, Tokyo, Japan) operated at an accelerating voltage of 100 kV. To 
evaluate the tubulation activity of MamY-GST protein in this experimental condition, GST 
protein was also evaluated as negative control, and no tubulation was found. 
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2.5 Binding assay between liposome containing CL and peptide array 
DOPC, CL and Texas red tagged DHPE (Thermo Fisher Scientific, Waltham, 
Massachusetts, USA) dissolved in chloroform were mixed with the ratio of 10:1:0.044 for 
CL-containing DOPC liposome or 10:0:0.04 for DOPC liposome. The mixture was dried 
under argon gas purging and kept in desiccator for more than 2 h. The obtained lipid cake 
was hydrated with PBS before 2-min sonication and then 30-s vortex. The lipid solution 
was extruded through 0.1 µm membrane using an extruder (Avanti Polar Lipids, Inc., 
Alabama, USA). 
The peptide array was blocked with 5% BSA in PBS for 30 min and triplicate 
washed with 0.05% Tween 20 in PBS for 3 min. The peptide array was soaked into the 
liposome solution diluted with PBS to 100 µg/ml for 1 h and triplicate washed with PBS 
for 3 min. All steps in binding assay were performed at 25°C with gentle agitation. 
Fluorescence scanning and imaging were performed by biomolecular imager (Typhoon 
FLA 9500, GE Healthcare, Uppsala, Sweden) using 653 nm excitation wavelength, 669 nm 
emission light wavelength with LPR filter at 50 mm-pixel size with 500 V. The 
fluorescence image was quantified by Image Quant software (GE Healthcare, Uppsala, 
Sweden). 
Dissociation constants (Kd) of candidate peptides with CL were determined by 
binding assay between liposomes and peptide array. The assay was tested at different 
liposome concentrations ranging from 0 to 150 µg/ml. Fluorescence intensity from 
binding assay with CL-containing DOPC liposome was subtracted by that with DOPC 
liposome to specify the binding intensity for CL. Binding curves were drawn between 
blank-subtracted intensity and CL concentration for Kd determination. Langmuirian 
binding isotherm equation {Y = Bmax×X/(Kd+X)} was used, where Y was blank-subtracted 
intensity, X was concentration of CL, and Bmax was the intensity at saturation. All Kd values 
were calculated from SigmaPlot 11.0 software (Systat Software Inc., California, USA).  
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To confirm the binding between candidate peptide and CL, binding assay by 
surface plasmon resonance (SPR) system (Biacore X100 Plus Package, GE Healthcare, 
Uppsala, Sweden) was conducted. AAFGKLNSASRAALI or AAAA peptide dissolved in 
acetate pH 5.5 to 0.5 mg/ml was immobilized on CM5 sensor chip surface using amine 
coupling kit at 5 µl/min for 18 min. The immobilized response was around 300 and 200 
RU for AAFGKLNSASRAALI and AAAA peptide, respectively. For binding analysis, the 
analyte, 10% CL-containing DOPC liposomes or DOPC liposomes diluted with HBS-EP 
buffer to 1 mg/ml, was applied at a flow rate of 10 µl/min for 180 s followed by 600 s of 
dissociation time. After each binding analysis, the surface was regenerated by 10 mM 
glycine-HCl pH 2. 0 at a flow rate of 10 µl/min for 1 min. 


3 Results  
3.1 Binding assay between MamY protein and various phospholipids using 
membrane lipid array 
To test whether MamY can bind to specific phospholipids, MamY-GST and a series 
of phospholipids were used to conduct a protein-lipid overlay binding assay. As shown in 
Fig. 1, unexpectedly, the unique binding properties of MamY protein to CL and 3-
sulfogalactosylceramide (sulfatide) were clearly observed by chemiluminescence 
detection (Fig. 1A), while no binding to other phospholipids including the major lipid 
components (PE; phosphatidylethanolamine, PS; phosphatidylserine, and PC; 
phosphatidylcholin) in the magnetosome membrane of M. magneticum AMB-1[36] were 
found. On the other hand, BAR domain of human Amphiphysin (AmphiphysinBAR, 
control) bound to phosphatidylinositols [PtdIns(4)P, PtdIns(4,5)P2, and PtdIns(3,4,5)P3], 
sulfatide, phosphatidic acid, phosphatidylserine (PS), phosphatidylethanolamine (PE), 
phosphatidylglycerol (PG) and CL (Fig. 1B), while the negative control (GST) showed no 
binding ability to any lipids on the lipid array as also reported previously[53] (Fig. 1C). 
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Among a range of negatively charged lipids in the strip, only two negatively charged lipids 
(CL and sulfatide) showed binding to MamY protein. The observation suggested that 
although a negative charge is essential, the interaction is not derived simple from 
electrostatic interaction.  The unique feature of protein binding specifically to CL and 
Sulfatide has previously been reported for α-helices regions in some proteins[54,55]. While 
the binding mechanism is still unclear in these proteins, similar interaction may 
contribute to the binding here because the MamY protein is also predicted to be dominant 
by α-helices regions[47]. Sulfatide is the major acidic glycosphingolipid in central and 
peripheral nerve myelin in mammals[56]. As the lipid group of glycosphingolipids including 
Sulfatide is generally synthesized only in eukaryotic cell with a few exceptions[57,58], we 
focused on the interaction between MamY and CL in the following experiments.  
 
3.2 Tubulation assay of liposome containing CL by MamY protein 
MamY has been previously shown to have deformation function of liposomes from 
spherical to tubulated morphology[47]. As the interaction between MamY and CL was 
confirmed in this study, as the next step, it was investigated whether the interaction 
enhances the liposome tubulation in vitro. In the presence of MamY-GST protein, liposome 
tubulation was clearly observed, while liposomes were spherical morphologies in the 
absence of MamY (Fig. 2). In addition, as found in Table 1, the tubulation efficiency was 
increased according to the increase of CL concentration. When the liposome was made of 
pure magnetosome membrane lipids (ML), the tubulation efficiency was 3.3%. It should be 
noted that the GST tag has a negligible effect on the liposome tubulation activity of MamY 
(tubulation activity of MamY-GST (3.3%) was similar level to MamY without GST tag 
(approximately 4%)[47]). GST protein also showed no liposome tubulation activity.  At 5%, 
10% and 20% of CL, a tubulation efficiency of approximately 20% was reached. This result 
demonstrated that MamY interacts with CL, and the interaction is associated with 
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liposome tubulation. The tubulation efficiency of liposome comprising magnetosome 
lipids supplemented with CL seems to be maximum at approximately 20%, and all MamY 
molecule seems to be used for the tubulation of liposome containing 5% or more CL. 
 
3.3 Binding assay between MamY derived peptides and CL containing liposome 
using peptide array 
To begin to understand the location of the CL binding region and mechanism of 
how MamY binds to CL, a 15-mer peptide library (188 peptides) constructed by 
overlapping 2 amino acids along the sequence of MamY protein (389 amino acids) was 
synthesized (Fig. 3A). A binding assay of this array to CL-containing DOPC liposome and 
DOPC liposome (control) was performed (Fig. 3). Some peptide spots showed higher 
intensity with CL-containing DOPC liposome than DOPC liposome (Fig. 3B). In addition, 
previously reported CL binding peptide[59](shown as “C” peptide in Fig. 3B), KNKEKK, 
shows binding only for CL-containing DOPC liposome. In order to quantitatively evaluate 
the binding to CL, the fluorescence intensity profile of DOPC liposome was subtracted 
from CL containing DOPC liposome (Fig. 3C). Herein, 8 peptides having greater intensity 
than average (+ 2SD value were selected as CL binding peptides (Table 2)) and the 
intensity was remarkably higher than the control peptide. SPR experiment using a 
screened CL binding candidate peptide (AAFGKLNSASRAALI) and tetra-alanine peptide 
(negative control) was applied to confirm the results from binding assay. In this assay, 
each peptide was immobilized on a sensor chip surface, and subsequently the solution 
containing liposome was flowed to observe the bound mass proportion on the surface 
along time. From blank-subtracted SPR sensor-gram, the bound mass or response on 
AAFGKLNSASRAALI peptide-immobilized surface was larger when CL-containing DOPC 
liposome was flowed (Supplementary figure 1-A). From this data, strong binding activity 
of screened peptide to CL was clearly confirmed by comparison with only DOPC 
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liposomes. In contrast, AAAA peptide-immobilized surface display insignificant difference 
with the both types of liposome (Supplementary figure 1-B). In addition, a protein region 
from aa280 to aa339 seems to be important for CL binding because 4 peptides were 
collectively found. As the peptides had a wide range of isoelectric point (pI) from 4.53 to 
11.54 and of the GRAVY (grand average of hydropathy) value from -1.91 to 0.67, various 
types of interaction to CL in each peptide may occur.  
The dissociation constant (Kd) of 8 candidate peptides (named p1-p8) to CL along 
with control peptide were determined by binding assay with CL-containing DOPC 
liposome and DOPC liposome using peptide array. By using the Langmuirian binding 
isotherm equation (see materials and methods), each Kd value of candidate peptides to CL 
was calculated (Table 2) (Supplementary figure 2). All candidate peptides except p2 have 
stronger affinity to CL than control peptide (KNKEKK, Kd=9.49 µM) in this experimental 
condition. Among these peptides, p6 (RKFISTLTTAYFAGD) showed the strongest affinity 
to CL (Kd=0.65 µM). The pI (8.59), GRAVY (0.07) and net charge (+1) were relatively 
neutral in this CL binding peptide candidates.  
 
4 Discussion  
In this study, the interaction between a prokaryotic membrane deformation 
protein, MamY, and CL was found. From the binding assay between CL and peptide library 
derived from MamY amino acid sequence, some peptides were suggested to play an 
important role for the interaction. This is the first report showing the direct interaction 
between magnetosome membrane protein and specific lipid. Furthermore, by the 
supplementation of CL to liposome, the effective liposome tubulation condition was 
developed.  
Binding of MamY protein to negatively charged CL was disclosed in this study. In 
this experimental condition (pH=7.4), the protein (pI=5.38) seems to be a generally 
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negatively charged molecule. This is interesting because the result suggests that the 
interaction is not simply derived from electrostatic interaction as a whole protein 
molecule. By evaluation of binding between peptide sequences derived from MamY and CL, 
as all 8 peptides included positively charged amino acids (R or K) and hydrophobic amino 
acids (e.g., V, I, L)(Table 2), both of the electrostatic and hydrophobic interaction seem to 
be contributed for the binding to CL. A lipid bilayer is a dynamic environment with varying 
properties ranging from nonpolar within the hydrocarbon chain to the polar headgroup-
solution interface. Therefore, selective binding may occur between various amino acids 
within the screened peptides interacting with the CL molecule. In addition, it is reported 
that some α-helix repeat structure within the protein relate to the stable binding to other 
biological membranes and its deformation[60,61], the structural feature of MamY protein 
comprising of repeat of α-helix may also contribute to the stable binding to CL. In fact, all 8 
candidate peptides were found in α-helix regions of MamY protein predicted by 
PSIPRED(http://bioinf.cs.ucl.ac.uk/psipred/)[62](Supplementary figure 2). On the other 
hand, since there is no report of 3D structure of MamY protein thus far, it is still unclear 
whether these peptides interact at plural sites or at nearby sites in the protein structure. 
Further study including protein structural analysis should be addressed to fully 
understand the molecular mechanism of magnetosome vesicle regulation by MamY 
protein.  
The supplementation of CL in liposome enhanced the tubulation efficiency by 
MamY protein, but the mechanism of liposome tubulation is still unclear. CL is an anionic 
tetraacylphospholipid which is almost exclusively confined to the innermitochondrial 
membrane in eukaryotic cells, whereas in prokaryotes, it has been identified in the 
cytoplasmic membrane. For example, CL-enriched membrane domains were reported in 
bacterial cells, E. coli[29,30], Bacillus subtilis[64] and Pseudomonas putida[65]. As a result of its 
conical shape, CL employs lateral pressure on a membrane containing other 
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phospholipids, and results in membrane curvature formation. In fact, in E. coli cells, CL is 
localized at the cell poles due to the membrane curvature[29,30]. As the size of magnetosome 
vesicle is approximately 100 nm, the membrane seems to be one of the most highly-curved 
membrane structure in magnetotactic bacteria. Therefore, MamY may play important role 
for the recruitment of CL to magnetosomes in order to induce the formation of highly-
curved vesicle formation and/or stabilization of the structure. The hypothesis is also 
supported by the bioinformatics analysis. Based on the protein domain analysis of MamY 
by Pfam[47], p4 and p7 are expected to have a similarity with caspase recruitment 
domain[66], involving in apoptotic signaling and requiring CL as a binding platform to 
recruit apoptotic factors[67]. In addition, based on the proteomic and genomic studies in 
magnetotactic bacteria, dozens of proteins including filamentous MamK protein and 
functionally unclear proteins have been suggested to play important roles for 
magnetosome formation[36,39,40,68,69]. In eukaryotic cells, as BAR protein regulates the 
intracellular vesicle formation cooperated with filamentous actin protein and with various 
other proteins[70], MamY protein may also function to form the magnetosome vesicle 
cooperatively with other magnetosome proteins. By the utilization of these proteins with 
MamY, liposome tubulation efficiency may be further improve. As shown in other 
literatures reported about liposome tubulation proteins[28,52,71–73], further investigations 
about MamY function in both in vivo and in vitro, including the dynamics analysis of each 
lipid and protein molecules by real time monitoring during liposome tubulation, protein 
structural analysis and detail TEM image analysis of tubulated liposomes would clarify the 
importance of this interaction in liposome tubulation and in magnetosome formation of 
magnetotactic bacteria. 
 In summary, the interaction of MamY protein and the partial amino acid sequences 
of MamY with CL was demonstrated in this study. In addition, the supplementation of CL 
into liposome revealed the enhancement of lipid tubulation efficiency by MamY protein. 
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The results in this manuscript not only give us the hint to effectively synthesize lipid 
tubule by prokaryotic protein but also might suggest the presence of unique protein-lipid 
interaction for magnetosome formation in magnetotactic bacteria. The liposome 
tubulation event, investigated in this study, was induced by the external stimuli of protein 
addition. This technique could be useful tool for elucidation of biological reactions 
onto/within membrane structures with different curvature. In addition, although the 
synthesis efficiency of lipid tubule is still low (approximately 20%), the synthesized 
materials with unique characteristics, such as biocompatibility, high dispersibility, and the 
potential of diameter tuning with a further molecular engineering technique, could be 
useful for various applications in nanobiotechnology. 
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Table 1. Evaluation of liposome tubulation activity in the presence of CL. 
Magnetosome lipid : Cardiolipin Tubulated/Observed Efficiency (%) 
100 : 0 6/183 3.3 
97.5 : 2.5 13/175 7.4 
95 : 5 41/203 20.2 
90 : 10 38/224 17.0 
80 : 20 33/179 18.4 
100 : 0 (no protein) 0/168 0.0 
90 : 10 (no protein) 0/170 0.0 
 
Table 2. Characteristics of CL binding peptides obtained from MamY amino acid sequence. 
Name 
Peptide 
number 
Sequence 
Subtracted 
intensity
a)
      
(a.u. ×10
5
) 
pI
b) GRAVYc) Charged) Kd (µM)
e) 
p1 10 AAFGKLNSASRAALI 2.71±0.18 11.00 0.67 +2 4.75±0.78 
p2 142 FISTLTTAYFAGDKN 2.34±0.42 5.83 0.13 0 11.97±5.22 
p3 155 NRSEQLRRCAEDTES 2.08±0.26 4.87 ?1.91 ?1.1 1.62±0.61 
p4 105 RVLSQEITQELSQIT 2.04±0.45 4.53 ?0.28 ?1 2.02±0.47 
p5 163 RQQISKILREAREIR 1.94±0.27 11.54 ?1.17 +3 1.19±0.19 
p6 141 RKFISTLTTAYFAGD 1.92±0.22 8.59 0.07 +1 0.65±0.31 
p7 104 SQRVLSQEITQELSQ 1.56±0.17 4.53 ?0.82 ?1 1.36±0.33 
p8 26 GWKNLFTMLPHEFFI 1.55±0.14 6.75 0.31 +0.1 2.31±0.37 
C C KNKEKK 0.45±0.11 10.0 ?3.77 +3 9.49±3.58 
a) The fluorescence intensity was shown from the intensity of CL containing DOPC 
liposome subtracted with DOPC liposome. b), c) and d) were analyzed using the 
ProtParam tool in ExPASy (http://web.expasy.org/protparam/). a) and e) Average values 
(±SD) are based on triplicate peptide spots.  
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Figure legends 
Figure 1. Dot-blot assay of MamY protein for the interactions with phospholipids. 
Nitrocellulose-immobilized phospholipids at 100 pmol per spot were incubated with 0.5 
μg ml-1 of proteins (A; MamY-GST, B; AmphiphysinBAR-GST, and C; GST). Top image shows 
the lipid profiles in array. Binding of proteins was detected by anti-GST HRP conjugated 
antibody with chemiluminescent substrate.  
 
Figure 2. Liposome tubulation assay with MamY protein. Representative electron 
micrographs of the magnetosome membrane extracted lipid liposome (ML) with CL 
supplementation (5%) (right) and without the supplementation (left) before (top) and 
after (middle) the MamY protein addition at 30 μM. The bottom images were enlarged 
from the square region in middle images to show the lipid tubule structure. The images 
are representative of several independent experiments. The tubulation efficiency was 
shown in Table 1. 
 
Figure 3. Evaluation of CL binding property in peptide library comprising partial 
sequences in amino acid sequence of MamY protein by using the peptide array. 
Designed peptide array (A) and the fluorescent images of peptide arrays after binding 
with (B-1) CL containing DOPC liposome and (B-2) only DOPC liposome. (C) Fluorescent 
intensity profile of each peptide spot; the intensity from CL containing DOPC liposome was 
subtracted from the intensity of only DOPC liposome. Error bar indicates SD derived from 
triple results. 
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Supplementary figure 1. Blank-subtracted SPR sensorgrams of binding analysis from (A) 
AAFGKLNSASRAALI peptide-immobilized chip and (B) AAAA peptide-immobilized chip in 
case of flowing 10% CL-containing DOPC liposome and DOPC liposome. The contact time 
is 180 s. The higher response could be seen when CL-containing liposome was flowed over 
AAFGKLNSASRAALI peptide-immobilized chip. 
 
Supplementary figure 2. Evaluation of dissociation constant (Kd) of 8 CL binding peptide 
candidates using peptide array. Synthesized peptide arrays were incubated in the solution 
containing DOPC with CL and without CL. (A) The top images show the peptide array after 
binding assay with different concentration of liposome. (B) In order to obtain the Kd value 
of candidate peptides to CL, subtracted fluorescence intensities were plotted from the 
different intensities between binding assays with CL-containing DOPC liposome and DOPC 
liposome. Error bar indicates standard deviation (SD) derived from triple results. 
 
Supplementary figure 3. Predicted secondary structure of MamY protein by PSIPRED 
with identified CL binding peptide regions. Screened peptides as CL binder were 
underlined. 
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Figure 1. Dot-blot assay of MamY protein for the interactions 
with phospholipids. 
Nitrocellulose-immobilized phospholipids at 100 pmol per spot 
were incubated with 0.5 ȝg ml-1 of proteins (A; MamY-GST, B; 
AmphiphysinBAR-GST, and C; GST). Top image shows the 
lipid profiles in array. Binding of proteins was detected by anti-
GST HRP conjugated antibody with chemiluminescent 
substrate.  
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+ MamY-GST 
- MamY-GST 
Figure 2. Liposome tubulation assay with MamY protein. 
Representative electron micrographs of the magnetosome 
membrane extracted lipid liposome (ML) with CL supplementation 
(5%) (right) and without the supplementation (left) before (top) and 
after (middle) the MamY protein addition at 30 ȝM. The bottom 
images were enlarged from the square region in middle images to 
show the lipid tubule structure. 
+ MamY-GST 
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Figure 3. Evaluation of CL binding property in peptide library comprising 
partial sequences in amino acid sequence of MamY protein by using the 
peptide array. 
Designed peptide array (A) and the fluorescent images of peptide arrays 
after binding with (B-1) CL containing DOPC liposome and (B-2) only 
DOPC liposome. (C) Fluorescent intensity profile of each peptide spot; 
the intensity from CL containing DOPC liposome was subtracted from 
the intensity of only DOPC liposome. Error bar indicates SD derived 
from triple results. 
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A.   AAFGKLNSASRAALI    B.   AAAA   
Supplementary figure 1. Blank-subtracted SPR sensorgrams of binding analysis from
(A) AAFGKLNSASRAALI peptide-immobilized chip and (B) AAAA peptide-immobilized
chip in case of flowing 10% CL-containing DOPC liposome and DOPC liposome. The
contact time is 180 s. The higher response could be seen when CL-containing liposome
was flowed over AAFGKLNSASRAALI peptide-immobilized chip.
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B
Supplementary figure 2. Evaluation of dissociation constant (Kd) of 8 CL binding peptide
candidates using peptide array. Synthesized peptide arrays were incubated in the solution
containing DOPC with CL and without CL. (A) The top images show the peptide array after
binding assay with different concentration of liposome. (B) In order to obtain the Kd value of
candidate peptides to CL, subtracted fluorescence intensities were plotted from the different
intensities between binding assays with CL-containing DOPC liposome and DOPC
liposome. Error bar indicates standard deviation (SD) derived from triple results.
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Supplementary figure 3. Predicted secondary structure of MamY protein with CL binding
peptide regions screened using peptide array. Screened peptides as CL binder were
underlined.
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